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Epstein-Barr virus? They have been leading
practitioners on EBV-ology since their dis-
covery of the virus in 1964, and are well
placed to provide the first comprehensive
digest of all aspects of the research that has
been done since then. Let it be said straight
away that this is an excellent book, and the
editors are to be congratulated on their
own contributions and on assembling such
a distinguished group of other authors. All
have made important contributions to their
subject, and the chapters carry the authority
and excitement that one would expect. They
provide an account of the evolution ofknow-
ledge and ideas in EBV research, highlight
the role serendipity has played, and show
how this research has reached far beyond
the confines of Burkitt's lymphoma, which
started it all off. The book is directed pri-
marily to the research worker, though the
clinician will find much of interest on the
scientific foundations of the EBV-related
diseases.
The first two chapters, by Epstein and
Achong, describe the discovery, general
biology, and morphological features of EBV.
Even now, no one knows with certainty
whether EBV causes Burkitt's lymphoma,
but, in the process of trying to find out.
scientists have discovered its causal role in
infectious mononucleosis and its association
with nasopharyngeal carcinoma. Detailed
reviews of the relationship of EBV to these
clinical conditions are described in later
chapters by Epstein and Achong, the Henles,
and Klein. The in vitro transformation of
human B lymphocytes by EBV as described
by Pope, and Nilsson provides an extensive
review of the characteristics of EBV-related
and other lymphoid cell lines. Such lines
have been the lodestone of EBV research,
and have been used in numerous areas of
study. Their use in studies on EBV-induced
antigens is clearly and concisely reviewed by
Ernberg and Klein. The biochemistry and
molecular biology of EBV, and the use of
molecular probes to study clinical problems,
are dealt with in chapters by Becker, Pagano
and Shaw, and ziir Hausen. Adams discusses
the state of the virus genome in transformed
cells, Strominger and Thorley-Lawson review
early events during transformation, and
Hamper provides a review of spontaneous
and induced activation oflatent viral genome.
Such studies yield clues to the various
states of the EBV-cell interaction which
will lead to an explanation of the variable
outcome of infection.
Lymphomas and other responses have
been induced with EBV in primates and this
approach is reviewed by Miller. The lessons
to be learned from studies on the oncogenicity
of other herpesviruses in animals are con-
sidered by F. and J. Deinhardt.
Another central area of EBV research has
been seroepidemiology, reviewed in relation
to the various EBV-related diseases by the
Henles. This theme is pursued further by
de-The, who describes the prospective study
set up in Uganda to define the relationship
between EBV and Burkitt's lymphoma.
The book ends hopefully with thoughtful
discussions by de-The and by Epstein on the
possibility of reducing the incidence of
EBV-related diseases by intervention directed
against either postulated cofactors, such as
malaria in the case of Burkitt's lymphoma,
or directly by use of vaccines against EBV.
This book can be wholeheartedly recom-
mended as a record of past achievement,
of the state of the art in 1978, and as a guide
to the future direction of research, and it
will be an essential work of reference for all
with an interest in EBV.
L. N. PAYNE
National Cancer Institute Monograph
No. 49. Workshop on Geniturinary
Cancer Immunology. (Ed.) W. BONNEY
(1976). USDHEW. 403 pp. $10.75.
Although genitourinary cancer accounts
for at least a third of the deaths from cancer,
the opening chapter gives an indication of
how under-represented are these tumours as
subjects of laboratory studies, accounting
for less than 7% of all the human neoplastic
cell lines available to the reviewer at the time
he wrote his chapter. This conference publi-
cation tries to make up for this deficiency by
providing an extensive compilation of basic
and applied laboratory studies in the field
ofgenitourinary cancer immunology. Though
succeeding in terms of providing an easily
readable reference volume which is well laid
out with good illustrations, the rather large
number of one- and two-page anecdotal
chapters does detract from the more sub-
stantial studies. The most important sections
are those which relate to tumour markers,1010 BOOK REVIEWS
in both testicular and prostatic tumours.
and the extensive discussion between sections
is particularly useful for tying together the
different assays and opposing views.
Other topics well covered are in the section
on animal models and attempts at demon-
strating specific antitumour immunity. From
the clinical point of viewi the section on
immunotherapy clearly indicates that little
has yet been achieved, but as none of the
studies reported had more than 20 patients,
the positive results in the studies of BCG
in bladder and kidney tumour did provide
some encouragement.
The final section relates to studies of
tumour regression after cryosurgery to the
prostate. In a disease where chemotherapy
has contributed little, this approach obviouslv
deserves further evaluation.
This book may prove of value to reference
libraries in centres with major urological
departments.
R. T. D. OLIVER
Progress in Experimental Tumour
Research Vol 25: Current Cancer
Immunology. (Ed) V. RICHARDS (1980).
Basel: Karger. 296 pp. US$87.00.
Progress is an optimist's word for change.
This excellent series of books returns once
again (the 3rd time in 25 volumes) to tumour
immunology, to document recent changes in
the topic. The emphasis of this volume is on
the clinical achievements of tumour immuno-
logy, and consequently it provides few signs
of anything that even an optimist would call
progress.
In the first 60 pages Dr Victor Richards
attempts the impossible by trying to sum-
marize the whole of immunology in a chapter
which he calls an "overview". This results,
as one might expect, in oversights. Proof-
reading errors are abundant (e.g. "homograft
resection" and 'anti-idiopathiccells"). Theuse
of outdated terminology and his enthusiasm
for blocking factors conveys a powerful
sense of deja vu. He states with confidence
(on p. 26) that every human neoplasm,
adequately studied, contains specific antigens
which elicit host responses. He may well be
right, but such an uncritical acceptance of
inadequate data is surprising. Ending, of
course, on a note of exuberant optimism he
tells us (in a cliche repeated by other con-
tributors) that 'immunotherapy of human
cancer is in its infancy". This remarkable
case of arrested development is clearly
documented in the rest of the book.
Apart from a useful section written by the
Montreal group on immunological methods
of diagnosis, the rest are familiar and opti-
mistic accounts of immunotherapy. Between
them the various authors weave a web of
Byzantine complexity in their attempts to
convince us thatimmunotherapyis, orisabout
to become, an effective form of treatment.
Much ofthe evidence presented ofthe benefits
of BCG, transfer factor, immune RNA,
levamisole and specific antibodies is poorly
controlled, and any attempt by your humble
reviewer to detail the inadequacies of these
studies would undoubtedly attract the atten-
tions of Koestler's Society for the Prevention
of Cruelty to Dead Horses.
By concentrating on the clinical aspects of
tumour immunology this disappointing book
might lead one to suppose that there has
been little progress in this subject over the
past 10 years. There have been substantial
changes, but then, change is a pessimist's
word for progress.
G. A. CURRIE
Malignancies of the Ovary, Uterus and
Cervix. R. S. BUSH(1979). London: Arnold.
243 pp. £13.95.
This is the second book in a 'Management
ofMalignant Disease Series" and is concerned
with those aspects ofthe major gynaecological
malignancies which contribute to the final
decisions about treatment. Dr Bush starts
with a very necessary discussion on "End
points for evaluating treatment" that will
be of benefit to anyone not working directly
in the onocological field.
The body of the text is devoted to the 3
major gynaecological malignancies, carcino-
mas of the ovary, uterine body and cervix,
and they are presented in the standard form:
natural history, evaluation and management.
There is no attempt to go into the technical
details of the surgical and radiotherapeutic
treatments involved, except where these
relate to the different management schemes.
In tackling these difficult subjects the
author manages to present well reasoned
arguments that lead to an understanding of
the Princess Margaret approach. The text